Concepedia

Hanka J. de Voogd

HJ

Statistics

Publications

2

Citations

72

H-Index

2

Active since

2004

Affiliations

Solvay (Netherlands)(Current)

Hanka J. de Voogd is an author at Solvay (Netherlands) specializing in heart failure, cardiovascular pharmacology, and pulmonary vascular disease.

Top concepts

Publications per year

2004–2012

2

Publications

2

Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure

Kenneth Dickstein, Hanka J. de Voogd, Milutin Mirić et al. · The American Journal of Cardiology · 2004 · 43 citations

, , +12

The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans

Alison Seed, Rhoda E. Kuc, Janet J. Maguire et al. · Life Sciences · 2012 · 29 citations · Full text

Rows per page

1–2 of 2